- ByInvesting.com-
Investing.com -- Hyloris Pharmaceuticals has encountered a regulatory hurdle for its Valacyclovir oral suspension after the FDA...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 285.60 | 286.80 | 276.00 | +9.60 | +3.48% | 18.43K | ||
| 92.70 | 93.70 | 92.10 | -0.70 | -0.75% | 14.5K | ||
| 116.25 | 117.70 | 115.80 | -1.15 | -0.98% | 46.77K | ||
| 26.92 | 27.30 | 26.78 | -0.38 | -1.39% | 42.88K | ||
| 83.95 | 84.50 | 83.70 | -0.30 | -0.36% | 16K | ||
| 287.60 | 289.50 | 285.00 | +2.20 | +0.77% | 23.59K | ||
| 66.48 | 66.70 | 65.84 | -1.06 | -1.57% | 623.37K | ||
| 62.60 | 63.10 | 62.35 | -0.20 | -0.32% | 53.59K | ||
| 18.61 | 18.97 | 18.45 | -0.33 | -1.74% | 99.59K | ||
| 78.55 | 79.40 | 77.95 | -0.70 | -0.88% | 26.27K | ||
| 133.40 | 133.40 | 130.80 | -0.40 | -0.30% | 154.82K | ||
| 10,420.0 | 10,420.0 | 10,240.0 | +180.0 | +1.76% | 105 | ||
| 58.00 | 58.75 | 57.95 | -0.80 | -1.36% | 9.8K | ||
| 74.00 | 74.40 | 72.90 | -0.50 | -0.67% | 14.25K | ||
| 247.60 | 248.20 | 245.80 | +1.60 | +0.65% | 3.15K | ||
| 25.28 | 25.30 | 25.08 | -0.02 | -0.08% | 84.03K | ||
| 189.80 | 190.50 | 189.30 | -0.70 | -0.37% | 11.71K | ||
| 723.40 | 729.00 | 718.80 | +9.00 | +1.26% | 9.46K | ||
| 9.19 | 9.40 | 8.98 | +0.62 | +7.23% | 204.55K | ||
| 78.32 | 78.80 | 77.82 | -1.00 | -1.26% | 6.47K |
Investing.com -- Hyloris Pharmaceuticals has encountered a regulatory hurdle for its Valacyclovir oral suspension after the FDA...
Investing.com -- Belgian logistics real estate company VGP (BR:VGP) on Thursday reported mixed results for 2025, with recurring...
Investing.com -- Aedifica reported a 6.8% increase in rental income to €361 million for fiscal year 2025, in line with market...
Upcoming U.S. retail sales data is expected to influence market perceptions, building on a recent increase. Companies like Target...
After the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX) dropped from its yearly high of...
Dividend stocks can provide regular income and outperform the broader market. When building a dividend portfolio, investors should...